AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Healthcare Stocks See Mixed Performance in Thursday's After-Market Session
ByAinvest
Thursday, Jul 17, 2025 7:26 pm ET1min read
Healthcare stocks moved significantly in Thursday's after-market session. Telomir Pharmaceuticals' stock increased by 52.1% to $1.84, while Brainstorm Cell Therapeutics' stock decreased by 49.6% to $0.59. Other notable gainers include VYNE Therapeutics, Nurix Therapeutics, Synlogic, and Salarius Pharmaceuticals. Losers include Redhill Biopharma, Sonoma Pharmaceuticals, Plus Therapeutics, Vivani Medical, and Verrica Pharmaceuticals.
Healthcare stocks experienced significant movement in Thursday's after-market session. Telomir Pharmaceuticals' stock surged by 52.1% to $1.84, while Brainstorm Cell Therapeutics' stock declined by 49.6% to $0.59. Other notable gainers included VYNE Therapeutics, Nurix Therapeutics, Synlogic, and Salarius Pharmaceuticals. Conversely, Redhill Biopharma, Sonoma Pharmaceuticals, Plus Therapeutics, Vivani Medical, and Verrica Pharmaceuticals were among the losers [2].Telomir Pharmaceuticals' stock increased by 52.1% to $1.84, reflecting strong market sentiment towards the company. Meanwhile, Brainstorm Cell Therapeutics' stock decreased by 49.6% to $0.59, indicating a significant drop in investor confidence. VYNE Therapeutics' shares rose by 6.77% to $1.26, following positive developments in its VYN202 program for moderate-to-severe plaque psoriasis. Nurix Therapeutics' stock moved upwards by 6.45% to $12.87, while Synlogic's stock increased by 6.02% to $1.76. Salarius Pharmaceuticals' stock also saw a gain of 5.33% to $0.63 [2].
Redhill Biopharma's stock fell by 8.68% to $2.21, Sonoma Pharmaceuticals' stock declined by 7.44% to $3.31, Plus Therapeutics' stock decreased by 6.58% to $0.36, Vivani Medical's stock fell by 5.67% to $1.5, and Verrica Pharmaceuticals' stock dropped by 5.29% to $0.81 [2].
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3TC0AI:0-australian-healthcare-stocks-gain-as-csl-advances-to-1-1-2-month-high/
[2] https://www.benzinga.com/insights/movers/25/07/46482121/12-health-care-stocks-moving-in-thursdays-after-market-session
[3] https://finance.yahoo.com/news/vyne-therapeutics-inc-vyne-gets-231802093.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet